Stocks · Health care · Pharmaceutical Preparations

Amneal Pharmaceuticals, Inc.

AMRX Clue Score38
Fiscal year ends December CIK 0001723128 Results filed 3 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
J Kevin Buchi
11 Sep 2026
Director
Exercised, kept
20,445
$14.45
$295.43K
John Kiely
13 Aug 2026
Director
Sell
50,000
$17.64
$882.00K
Jason B. Daly
12 Aug 2026
EVP, Chief Legal Officer
Sell
210,000
$17.40
$3.65M
Nikita Shah
12 Aug 2026
Executive Vice President
Sell
146,403
$17.51
$2.56M
Jason B. Daly
11 Aug 2026
EVP, Chief Legal Officer
Sell
6,613
$17.70
$117.05K
Deborah M. Autor
11 May 2026
Director
Sell
34,819
$12.94
$450.56K
Ted C Nark
17 Nov 2025
Director
Sell
50,000
$11.72
$586.00K
Nikita Shah
12 Nov 2025
Executive Vice President
Sold after exercise
131,856
$11.92
$1.57M

What was left out

Form 4 filings counted 35
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 1
Sales at will 6
Transactions with no price 0
Shares from compensation/vesting 32,313,464
History held since 8 May 2018